A systematic review on the safety of Ramadan fasting in high-risk patients with Diabetes



      Fasting the holy month of Ramadan is passionately practiced by all Muslim population around the world. Patients with diabetes are generally considered to have a higher risk of fasting. The current international guidelines have risk-stratified the patients with diabetes and other comorbidities to different categories, and the decision of fasting or not is made based on this categorization. Many studies looked at the impact of Ramadan fasting on those high-risk patients, and many are currently being in progress.


      In this systematic review, we conducted an extensive search in PubMed and google scholar engines. Studies filtration focused only on the Randomized controlled trial (RCT) and prospective observational studies accomplished between the year 2007 up to March2019 on impact of Ramadan on patients with diabetes at high risk of fasting.


      The global dissemination and implementation of the guidelines for the management of diabetes during Ramadan broke the inertia among health care providers. Additionally, the concept of pre-Ramadan assessment for risk categorization, therapeutic doses modification in hand with self -monitoring blood glucose; have markedly reduced the risk and hospitalisation during Ramadan.


      There is still limited data on fasting Ramadan by high risk patients with diabetes. There was minimal diversity in the published results, however, Generally and despite the education, self-titration; the incidences of complications during Ramadan is minimally higher than other times of the year in this group.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Guariguata L.
        • Whiting D.R.
        • Hambleton I.
        • Beagley J.
        • Linnenkamp U.
        • Shaw J.E.
        Global estimates of diabetes prevalence for 2013 and projections for 2035.
        Diabetes Res Clin Pract. 2014 Feb; 103: 137-149
      1. The Future of World Religions: Population Growth Projections; 2010–2050|Pew Research Center [cited 2017 Apr 27].

      2. Fischbacher CM, Bhopal R, Steiner M, Morris AD, Chalmers J. Is there equity of service delivery and intermediate outcomes in South Asians with type 2 diabetes? Analysis of DARTS database and summary of UK publications. [cited 2017 Apr 27];

        • Lanting L.C.
        • Joung I.M.A.
        • Mackenbach J.P.
        • Lamberts S.W.J.
        • Bootsma A.H.
        Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review.
        Diabetes Care. 2005; 28: 2280-2288
        • Salti I.
        • Bénard E.
        • Detournay B.
        • Bianchi-Biscay M.
        • Le Brigand C.
        • Voinet C.
        • et al.
        A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study.
        Diabetes Care. 2004 Oct; 27: 2306-2311
        • Ahmadani M.Y.
        • Riaz M.
        • Fawwad A.
        • Hydrie M.Z.I.
        • Hakeem R.
        • Basit A.
        Glycaemic trend during Ramadan in fasting diabetic subjects: a study from Pakistan.
        Pakistan J Biol Sci PJBS. 2008; 11: 2044-2047
        • Al-Arouj M.
        • Bouguerra R.
        • Buse J.
        • Hafez S.
        • Hassanein M.
        • Ibrahim M.A.
        • et al.
        Recommendations for management of diabetes during Ramadan.
        Diabetes Care. 2005; 28: 2305-2311
      3. Bonakdaran S. Physiology of Ramadan Fasting; 2016 [cited 2017 May 2];

        • Bottini P.
        • Boschetti E.
        • Pampanelli S.
        • Ciofetta M.
        • Del Sindaco P.
        • Scionti L.
        • et al.
        Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect.
        Diabetes. 1997; 46: 814-823
        • Lessan N.
        • Hannoun Z.
        • Hasan H.
        • Barakat M.T.
        Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM).
        Diabetes Metab. 2015; 41: 28-36
        • Alghadyan A.A.
        Retinal vein occlusion in Saudi Arabia: possible role of dehydration.
        Ann Ophthalmol. 1993; 25: 394-398
        • Hassanein Mohamed
        • Al - Arouj Monira
        • et al.
        Diabetes and Ramadan: practical guidelines.
        Diabetes Res Clin Pract. 2017; 126: 303-316
        • Alsaeed D.
        • Al-Kandari J.
        • Al-Ozairi E.
        Experiences of people with type 1 diabetes fasting Ramadan following structured education: a qualitative study.
        Diabetes Res Clin Pract. 2019; 153: 157-165
        • Zabeen B.
        • Tayyeb S.
        • Benarjee B.
        • Baki A.
        • Nahar J.
        • Mohsin F.
        • et al.
        Fasting during Ramadan in adolescents with diabetes.
        Indian J Endocrinol Metab Medknow Publ. 2014; 18: 44-47
        • Al-Khawari M.
        • Al-Ruwayeh A.
        • Al-Doub K.
        • Allgrove J.
        Adolescents on basal-bolus insulin can fast during Ramadan.
        Pediatr Diabetes Blackwell Publishing Ltd. 2010; 11: 96-100
        • AlAlwan I.
        • Al Banyan A.
        Effects of Ramadan fasting on children with Type 1 diabetes.
        Int J Diabetes Mellit. 2010; 2: 127-129
        • Deeb A.
        • Al Qahtani N.
        • Attia S.
        • Al Suwaidi H.
        • Nagelkerke N.
        Does Reducing basal insulin during Ramadan fasting by children and adolescents with type 1 diabetes decrease the risk of symptomatic hypoglycemia?.
        Diabetes Technol Ther. 2016; 18: 539-542
        • El-Hawary A.
        • Salem N.
        • Elsharkawy A.
        • Metwali A.
        • Wafa A.
        • Chalaby N.
        • et al.
        Safety and metabolic impact of Ramadan fasting in children and adolescents with type 1 diabetes.
        J Pediatr Endocrinol Metab. 2016; 29
        • Bin-Abbas B.S.
        Insulin pump therapy during Ramadan fasting in type 1 diabetic adolescents.
        Annals of Saudi Med. 2008; 28: 305-306
        • Benbarka M.M.
        • Khalil A.B.
        • Beshyah S.A.
        • Marjei S.
        • Awad S.A.
        Insulin pump therapy in moslem patients with type 1 diabetes during Ramadan fasting: an observational report.
        Diabetes Technol Ther. 2010; 12: 287-290
        • Khalil A.B.
        • Beshyah S.A.
        • Abu Awad S.M.
        • Benbarka M.M.
        • Haddad M.
        • Al-Hassan D.
        • et al.
        Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study.
        Diabetes Technol Ther. 2012; 14: 813-818
        • Kaplan W.
        • Afandi B.
        Blood glucose fluctuation during Ramadan fasting in adolescents with type 1 diabetes: findings of continuous glucose monitoring.
        Dia Care. 2015; 38: e162-e163
        • Alamoudi R.
        • Alsubaiee M.
        • Alqarni A.
        • Saleh Y.
        • Aljaser S.
        • Salam A.
        • et al.
        Comparison of insulin pump therapy and multiple daily injections insulin regimen in patients with type 1 diabetes during ramadan fasting.
        Diabetes Technol Ther. 2017; 19: 349-354
        • Bakiner O.
        • Ertorer M.E.
        • Bozkirli E.
        • Tutuncu N.B.
        • Demirag N.G.
        Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
        Acta Diabetol. 2009; 46: 63-65
        • Cesur M.
        • Corapcioglu D.
        • Gursoy A.
        • Gonen S.
        • Ozduman M.
        • Emral R.
        • et al.
        A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting.
        Diabetes Res Clin Pract. 2007; 75: 141-147
        • Salti I.
        Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan.
        Diabet Med. 2009; 26: 1255-1261
        • Akram J.
        • De Verga V.
        Insulin lispro (Lys(B28), Pro(B29) in the treatment of diabetes during the fasting month of Ramadan. Ramadan study group.
        Diabetic Med. 1999; 16: 861-866
        • Hui E.
        • Bravis V.
        • Salih S.
        • Hassanein M.
        • Devendra D.
        Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan.
        Int J Clin Pract. 2010; 64: 1095-1099
        • Mattoo V.
        • Milicevic Z.
        • Malone J.K.
        • Schwarzenhofer M.
        • Ekangaki A.
        • Levitt L.K.
        • et al.
        A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan.
        Diabetes Res Clin Pract. 2003; 59: 137-143
        • Shehadeh N.
        • Maor Y.
        The Ramadan Study Group. Effect of a new insulin treatment regimen on glycaemic control and quality of life of Muslim patients with type 2 diabetes mellitus during Ramadan fast – an open-label, controlled, multicentre, cluster-randomized study.
        Int J Clin Pract. 2015; 69: 1281-1288
        • Soewondo P.
        • Adam J.M.
        • Sanusi H.
        • Soeatmadji D.W.
        A multicenter, prospective, non-interventional evaluation of efficacy and safety of using biphasic insulin aspart as monotherapy, or in combination with the oral hypoglycemic agent, in the treatment of type 2 diabetic patients before, during, & after Ramadan.
        J Indonesian Med Ass. 2009; 59: 574-579
        • Sanjay Kalra
        Insulin degludec and insulin degludec/insulin aspart in Ramadan: a single center experience.
        Indian J Endocrinol Metab. 2016; 20: 564-567, 180644. PMCID: PMC4911850
        • Mohamed Hassanein
        • Salim Echtay Akram
        • Rachid Malek
        • Mahomed Omar
        • Sajid Shaikh Shehla
        • Magnus Ekelund
        • Kadriye Kaplan
        • Azmi Kamaruddin Nor
        Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: a phase 3, multicentre, international, open-label, randomized, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan.
        Diabetes Res Clin Pract. 2018; 135: 218-226
        • Bashier Alaaeldin M.K.
        • Hussain Azza Khalifa Bin
        • Alawadi Fatheya
        • Alsayyah Fatima
        • Alsaeed Maryam
        • Rashid Fauzia
        • Abdelgadir Elamin
        • Bachet Fawzi
        • Abuelkheir Sona
        • Elsayed Mohamed
        • Hassanein Mohamed
        Impact of optimum diabetes care on the safety of fasting in Ramadan in adult patients with type 2 diabetes mellitus on insulin therapy.
        Diabetes Res Clin Pract. 2019; 150: 301-307
        • Lou A.
        • Hammoud M.
        Muslim patients’ expectations and attitudes about Ramadan fasting during pregnancy.
        Int J Gynaecol Obstet. 2016; 132: 321-324
        • Ziaee V.
        • Kihanidoost Z.
        • Younesian M.
        • Akhavirad M.-B.
        • Bateni F.
        • Kazemianfar Z.
        • et al.
        The effect of Ramadan fasting on the outcome of pregnancy.
        Iran J Pediatr. 2010; 20: 181-186
        • Ismail N.A.M.
        • Olaide Raji H.
        • Abd Wahab N.
        • Mustafa N.
        • Kamaruddin N.A.
        • Abdul Jamil M.
        Glycemic control among pregnant diabetic women on insulin who fasted during Ramadan.
        Iran J Med Sci. 2011; 36: 254-259
        • Nor Azlin M.I.
        • Adam R.
        • Sufian S.S.
        • Wahab N.A.
        • Mustafa N.
        • Kamaruddin N.A.
        • et al.
        Safety and tolerability of once or twice daily neutral protamine Hagedorn insulin in fasting pregnant women with diabetes during Ramadan.
        J Obstet Gynaecol Res. 2011; 37: 132-137
        • Bernieh B.
        • Al-Hakim M.R.
        • Boobes Y.
        • Abu Zidan F.M.
        Fasting Ramadan in chronic kidney disease patients: clinical and biochemical effects.
        Saudi J Kidney Dis Transpl. 2010; 21: 898-902
      4. Bakhit AA, Kurdi AM, Wadera JJ, Alsuwaida AO. Saudi medical journal. SMJ Saudi Med J 2017:48–52.

        • Kara E.
        • Sahin O.Z.
        • Kizilkaya B.
        • Ozturk B.
        • Pusuroglu G.
        • Yildirim S.
        • et al.
        Fasting in Ramadan is not associated with deterioration of chronic kidney disease: A prospective observational study.
        Saudi J Kidney Dis Transpl Medknow Publ Media Pvt. Ltd. 2017; 28: 68-75
        • Wan Md Adnan W.A.H.
        • Zaharan N.L.
        • Wong M.H.
        • Lim S.K.
        The effects of intermittent fasting during the month of Ramadan in chronic hemodialysis patients in a tropical climate country.
        PLoS One Public Library of Sci. 2014; 9: e114262
        • Alawadi F.
        • Rashid F.
        • Bashier A.
        • et al.
        The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care.
        Diabetes Res Clin Pract. 2019; 151: 305-312